Biểu đồ giá cổ phiếu RANI
RANI Dự đoán giá cổ phiếu
Rani Therapeutics Holdings Inc
$0
0%
$0
Khi đóng cửa: May 11, 16:00:00 GMT-4
$0
0%
$0
Phiên trước giờ: May 12, 04:19:51 GMT-4
Quay lại
Rani Therapeutics Holdings Inc (RANI) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
--
Giá mở cửa
--
Phạm vi ngày
-
Phạm vi 52 tuần
-
Khối lượng
--
Khối lượng trung bình
1.0M
Tỷ suất cổ tức
--
EPS (TTM)
-0.59
Vốn hóa thị trường
--
RANI là gì?
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company is headquartered in San Jose, California and currently employs 69 full-time employees. The company went IPO on 2021-07-30. The firm has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. The company has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. The company is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).
